Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CF101 in moderate-to-severe plaque psoriasis
NCT00428974Phase 2Completed
- Sponsor
- Can-Fite BioPharma Ltd.
- Start
- Jun 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of piclidenoson in plaque psoriasis, sponsored by Can-Fite BioPharma Ltd.. Started Jun 2007; status: completed.
02
Drugs
piclidenoson
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00428974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428974.